文献速递肾小球疾病遗传性与小管间质肾病

结节病相关膜性肾病的靶抗原异质性

Heterogeneity of Target Antigens in Sarcoidosis-Associated Membranous Nephropathy.
PubMed 文献 · Kidney Int Rep · 2023-04-05

该研究对18例有结节病病史且经活检证实膜性肾病的患者肾组织行质谱分析检测靶抗原,并用免疫组化确认定位。结果显示PLA2R占46.6%、NELL1占22.2%,另各1例THSD7A、PCDH7和Serpin B12阳性,4例(22.2%)未检出已知靶抗原。作者认为结节病相关膜性肾病靶抗原呈异质性,其分布可能反映膜性肾病总体靶抗原分布。

要点

  • 结节病相关膜性肾病靶抗原呈异质性,并非单一抗原所致。
  • 18例中PLA2R 7例(46.6%)、NELL1 4例(22.2%)。
  • THSD7A、PCDH7、Serpin B12各1例(5.5%),4例(22.2%)未检出已知抗原。

核心结论

  • 结节病相关膜性肾病靶抗原呈异质性,除PLA2R外还检出NELL1、PCDH7和THSD7A等既往未报告的抗原。
  • 结节病相关膜性肾病中靶抗原的分布似乎与膜性肾病总体靶抗原分布相仿。
  • 结节病中的膜性肾病可能是免疫反应增强的结果,与单一靶抗原无关。

研究设计与样本

  • 研究检索并分析有结节病病史且经活检证实膜性肾病患者的资料。
  • 对所有结节病相关膜性肾病肾活检组织行串联质谱(MS/MS)检测靶抗原。
  • 行免疫组化研究以确认靶抗原并定位其沿肾小球基底膜(GBM)的分布。
  • 共纳入18例有结节病病史且经活检证实膜性肾病的患者,其中3例已知为PLA2R阴性,其余患者靶抗原未知。

主要发现

  • 18例患者中13例(72%)为男性,膜性肾病诊断时中位年龄54.5岁。
  • 就诊时中位蛋白尿为9.8 g/24 h。
  • 8例(44.4%)合并活动性结节病。
  • MS/MS检出PLA2R 7例(46.6%)和NELL1 4例(22.2%)。
  • THSD7A、PCDH7和推定抗原Serpin B12各1例(5.5%)阳性,其余4例(22.2%)未检出已知靶抗原。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Membranous nephropathy (MN) is the most common glomerular disease associated with sarcoidosis. The target antigen M-type phospholipase A2 receptor 1 (PLA2R) has been identified in a subset of sarcoidosis-associated MN. The target antigen is not known in the remaining sarcoidosis-associated MN. METHODS: Data of patients with history of sarcoidosis and biopsy-proven MN were retrieved and analyzed. Mass spectrometry (MS/MS) was performed on all kidney biopsies of sarcoidosis-associated MN to detect the target antigens. Immunohistochemistry (IHC) studies were performed to confirm and localize the target antigens along the glomerular basement membrane (GBM). RESULTS: Eighteen patients with history of sarcoidosis and biopsy-proven MN were identified, of whom 3 were known to be PLA2R-negative, and in the remaining patients the target antigen was unknown. Thirteen (72%) patients were males; the median age at MN diagnosis was 54.5 years. The median proteinuria at presentation was proteinuria 9.8 g/24 h. Eight patients (44.4%) had concurrent sarcoidosis. Using MS/MS, we detected PLA2R and neural epidermal growth factor-like-1 protein (NELL1) in 7 (46.6%) and 4 (22.2%) patients, respectively. In addition, 1 case each (5.5%) was positive for thrombospondin type 1 domain-containing 7A (THSD7A), protocadherin-7 (PCDH7), and putative antigen Serpin B12. No known target antigen was detected in the remaining 4 patients (22.2%). CONCLUSION: Patients with sarcoidosis and MN exhibit heterogeneous target antigens. We identified, along with PLA2R, the presence of previously unreported antigens, including NELL1, PCDH7, and THSD7A. The incidence of the target antigens in sarcoidosis appears to mirror the overall incidence of target antigens in MN. MN in sarcoidosis may be the result of a heightened immune response and is not associated with a single target antigen.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Zubidat D, Madden B, Kudose S, et al. Heterogeneity of Target Antigens in Sarcoidosis-Associated Membranous Nephropathy. Kidney Int Rep. 2023. PMID: 37284677. doi:10.1016/j.ekir.2023.03.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。